Sonova stock edges lower after recent gains on SIX

Published on 09/16/2026 at 14:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sonova stock traded around CHF 227 on SIX on September 16, 2026 after intraday gains earlier in the session. Recent results for the hearing care group show higher sales and profitability compared with the prior year.

Professional architectural photography of a modern medical technology corporate headquarters building featuring floor-to-ceiling glass facade with structural transparency revealing bright open office floors, surrounded by manicured greenery and a reflecti — Sonova CH0012549785: Modernes Med-Tech-Headquarter mit transparenter Glasfassade, Spiegelbecken und Grünanlagen bei goldenem Abendlicht, Illustration mit AI erstellt.

Sonova stock (ISIN CH0012549785) traded around CHF 227 on the SIX Swiss Exchange on September 16, 2026, moving modestly lower intraday after a brief upswing earlier in the day.

Intraday moves and market context

According to finanzen.ch on September 16, 2026, Sonova shares were down about 0.4 percent at CHF 227.20 in morning trading on SIX at 09:28, compared with the previous official close, pointing to a mild consolidation after recent strength.

Later in the session, Sonova appeared among the stronger stocks in the Swiss Large and Mid Cap Index, with the shares up about 0.7 percent at CHF 229.80 per data cited by finanzen.ch at 12:26 on September 16, 2026, indicating that intraday buyers were willing to step in as broader Swiss large caps gained ground.

Recent revenue and earnings trends

Sonova Holding AG, a leading global provider of hearing care solutions, most recently reported higher revenue and earnings for the latest fiscal year compared with the prior year, reflecting continued demand for hearing instruments and cochlear implants; the company website’s investor section at Sonova summarizes these results and guidance for the current financial year.

In its latest reported period, Sonova’s sales and profitability increased versus the previous year, with revenue advancing at a mid-single-digit to low-double-digit percentage rate and earnings growing faster than sales, underscoring margin improvement in its core hearing care segment as documented in the recent annual and interim reports available through the company’s investor-relations pages at Sonova.

Stock level and investor view

With Sonova stock changing hands around the high-CHF-220 range on SIX on September 16, 2026, compared with intraday levels near CHF 229.80 earlier that day, the shares are trading in the upper part of their recent range, giving investors a picture of a hearing care specialist whose stronger earnings backdrop is now being weighed against short-term price fluctuations.